Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bioshares Biotech Clinical Trial (BBC)

Bioshares Biotech Clinical Trial (BBC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BioShares
  • Assets Under Management 27,616,500
  • Market Capitalization, $K 27,617
  • Shares Outstanding, K 950
  • 60-Month Beta 1.84
  • Price/Earnings ttm 0.00
  • Annual Dividend & Yield 0.30 (0.97%)
  • Most Recent Dividend 0.297 on 12/20/17
  • Management Fee 0.79%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.00 +32.70%
on 03/18/20
33.61 -9.20%
on 03/10/20
-4.62 (-13.15%)
since 03/06/20
3-Month
23.00 +32.70%
on 03/18/20
38.79 -21.32%
on 01/17/20
-6.91 (-18.46%)
since 01/08/20
52-Week
22.92 +33.16%
on 10/09/19
40.19 -24.06%
on 12/26/19
+0.83 (+2.79%)
since 04/08/19

Most Recent Stories

More News
5 Market-Beating Smart-Beta ETF Charts of 2019

These smart-beta ETFs beat the broader market with ease in 2019.

AMZN : 2,043.00 (+1.56%)
AAPL : 266.07 (+2.56%)
DIA : 234.33 (+3.41%)
FTXL : 35.92 (+4.15%)
QQQ : 200.57 (+2.12%)
BBC : 30.52 (+5.28%)
SPY : 274.03 (+3.36%)
QTUM : 25.00 (+2.71%)
GOAU : 13.61 (+1.25%)
Biotech Rally Sends Nasdaq to 9000: ETFs in Focus

Some biotech stocks have contributed materially to the Nasdaq's 1000-point gain since Aug 27, 2018 and helped it notch a record 9,000 on Dec 26.

CSCO : 41.74 (+2.71%)
AMZN : 2,043.00 (+1.56%)
FB : 174.28 (+3.23%)
GOOG : 1,210.28 (+2.00%)
AAPL : 266.07 (+2.56%)
MSFT : 165.13 (+1.00%)
BBC : 30.52 (+5.28%)
XPH : 37.44 (+3.88%)
AXSM : 58.20 (+16.70%)
INTC : 58.98 (+0.99%)
CNST : 32.40 (+8.00%)
SAVA : 5.04 (+8.62%)
KOD : 46.55 (+8.13%)
RCEL : 6.34 (+8.19%)
9 ETFs at the Forefront of 2019 Market Rally

As there have been winners in many corners of the space, we highlight nine ETFs from different zones that have outperformed so far this year. These are expected to continue outperforming, provided the...

PBW : 28.58 (+5.11%)
TAN : 27.49 (+4.09%)
SMH : 126.87 (+3.31%)
ITB : 32.33 (+8.31%)
BBC : 30.52 (+5.28%)
XLK : 85.18 (+2.69%)
GOAU : 13.61 (+1.25%)
QTUM : 25.00 (+2.71%)
SILJ : 7.29 (+1.11%)
Best & Worst ETFs of Fourth Quarter

Inside the top and worst-performing ETFs of the fourth quarter.

BBC : 30.52 (+5.28%)
JO : 37.86 (-0.42%)
PAK : 5.13 (+0.20%)
VXX : 42.40 (-2.33%)
PIN : 14.53 (+3.34%)
GAZ : 20.26 (-4.35%)
POTX : 8.82 (+1.38%)
CHIR : 16.30 (-0.31%)
4 Sector ETFs That Beat the Market in Q4

While Wall Street is surging this quarter, these sector ETFs offered even better performances to beat the market.

DIA : 234.33 (+3.41%)
SOXX : 222.40 (+3.35%)
IEZ : 7.12 (+6.59%)
BBC : 30.52 (+5.28%)
SMH : 126.87 (+3.31%)
PXJ : 2.05 (+5.65%)
SIL : 25.51 (+0.43%)
XSD : 90.93 (+3.60%)
SBIO : 33.40 (+4.34%)
XPH : 37.44 (+3.88%)
QQQ : 200.57 (+2.12%)
SPY : 274.03 (+3.36%)
GNOM : 13.14 (+2.54%)
SILJ : 7.29 (+1.11%)
Biotech Leading in Q4: Best ETFs & Stocks

We highlight five biotech ETFs and stocks that are leading the market in Q4.

SNY : 45.18 (+1.30%)
MRK : 81.62 (+3.90%)
RHHBY : 40.3500 (+0.82%)
NVS : 85.62 (+1.94%)
CNCR : 20.09 (+2.19%)
SBIO : 33.40 (+4.34%)
XBI : 81.89 (+3.93%)
BBC : 30.52 (+5.28%)
THOR : 67.99 (unch)
SRPT : 103.87 (+3.89%)
GBT : 62.33 (+6.11%)
VRTX : 249.66 (+0.80%)
AXSM : 58.20 (+16.70%)
CLSD : 1.7200 (+6.83%)
Will Biotech ETFs Excel in Election Year Post a Surge in 2019?

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

CNCR : 20.09 (+2.19%)
BBC : 30.52 (+5.28%)
PBE : 48.64 (+3.52%)
IBB : 112.94 (+3.10%)
XBI : 81.89 (+3.93%)
SBIO : 33.40 (+4.34%)
IDNA : 27.39 (+1.90%)
HTEC : 24.46 (+3.23%)
5 Market-Beating Sector ETFs of 2019

Braving all hurdles including recession fears, trade dispute, Brexit and geopolitical tensions, Wall Street has enjoyed a huge rally this year with all the three major indices hitting record highs lately....

ITB : 32.33 (+8.31%)
PBW : 28.58 (+5.11%)
TAN : 27.49 (+4.09%)
BBC : 30.52 (+5.28%)
SMH : 126.87 (+3.31%)
5 ETF Areas Up At Least 45% in 2019

These ETF areas crushed the S&P 500 in 2019.

ITB : 32.33 (+8.31%)
TAN : 27.49 (+4.09%)
PALL : 200.44 (-2.37%)
SOXX : 222.40 (+3.35%)
XSD : 90.93 (+3.60%)
PBW : 28.58 (+5.11%)
SMH : 126.87 (+3.31%)
SBIO : 33.40 (+4.34%)
FTXL : 35.92 (+4.15%)
BBC : 30.52 (+5.28%)
ACES : 30.49 (+3.25%)
Top Performing ETFs of 2019

We take a look at the best performing areas of the market

AMD : 48.79 (+2.59%)
PALL : 200.44 (-2.37%)
SOXX : 222.40 (+3.35%)
TAN : 27.49 (+4.09%)
BBC : 30.52 (+5.28%)
NVDA : 266.95 (+3.06%)
ENPH : 37.93 (+8.25%)
SEDG : 93.07 (+4.81%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade BBC with:

Fund Summary

The BioShares Biotechnology Clinical Trials Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their...

See More

Top 10 Holdings

Name % Holdings
Forty Seven Inc 3.47%
BNY MELLON CASH RESERVE USD 2.30%
Moderna Inc 2.24%
CEL-SCI Corp 1.93%
ChemoCentryx Inc 1.77%
Fate Therapeutics Inc 1.68%
Intra-Cellular Therapies Inc 1.55%
Translate Bio Inc 1.55%
Principia Biopharma Inc 1.51%
Cytokinetics Inc 1.48%

See More

Key Turning Points

2nd Resistance Point 31.33
1st Resistance Point 30.93
Last Price 30.52
1st Support Level 29.72
2nd Support Level 28.91

See More

52-Week High 40.19
Fibonacci 61.8% 33.59
Fibonacci 50% 31.56
Last Price 30.52
Fibonacci 38.2% 29.52
52-Week Low 22.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar